SG Americas Securities LLC Has $109.97 Million Position in Agilent Technologies, Inc. $A

SG Americas Securities LLC grew its position in Agilent Technologies, Inc. (NYSE:A) by 3,091.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 808,215 shares of the medical research company’s stock after acquiring an additional 782,888 shares during the period. SG Americas Securities LLC owned about 0.29% of Agilent Technologies worth $109,974,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of A. Bridgefront Capital LLC acquired a new stake in shares of Agilent Technologies in the third quarter valued at approximately $1,323,000. Envestnet Asset Management Inc. increased its holdings in shares of Agilent Technologies by 3.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after acquiring an additional 22,498 shares during the last quarter. CCLA Investment Management raised its stake in Agilent Technologies by 10.5% in the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after acquiring an additional 97,312 shares during the period. Osaic Holdings Inc. raised its stake in Agilent Technologies by 35.5% in the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after acquiring an additional 17,817 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Stock Up 0.6%

A stock opened at $112.02 on Tuesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market capitalization of $31.66 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 2.34 and a beta of 1.31. The business’s fifty day moving average price is $126.15 and its two-hundred day moving average price is $135.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the previous year, the firm posted $1.31 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s payout ratio is currently 22.52%.

Analyst Upgrades and Downgrades

A number of research firms have commented on A. Morgan Stanley reduced their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Barclays cut their target price on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. HSBC began coverage on shares of Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target on the stock. Finally, Robert W. Baird raised their price objective on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.